Artia Global Partners’s Biohaven BHVN Stock Holding History

Artia Global Partners’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-80,000	Closed	-$1.2M	–	57
2025 Q3	$1.2M	Hold	80,000	–	–	0.19%	41
2025 Q2	$1.13M	Buy	+80,000	New	+$1.43M	0.27%	31

Other funds holding BHVN

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artia Global Partners's BHVN Position: Q4 2025 in Review

Artia Global Partners sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 80,000 shares — an estimated $1.2M sold.

Artia Global Partners first reported a position in BHVN in Q2 2025 and held it in 2 quarters. The position peaked at $1.2M in Q3 2025. 273 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

Artia Global Partners reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
Artia Global Partners sold 80,000 Biohaven shares in Q4 2025, an estimated $1.2M.
Artia Global Partners first reported a position in Biohaven in Q2 2025 and held it in 2 quarters.
Artia Global Partners's Biohaven position peaked at $1.2M in Q3 2025.
273 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Artia Global Partners's 13F filing for Q4 2025, filed 17 Feb 2026.